Company
JapanPublic company, NYSE: TAKTakeda Pharmaceutical Company Limited (NYSE: TAK), Round Lake, Japan – FDA Inspections
Inspection records and compliance data for Takeda Pharmaceutical Company Limited in Round Lake, Illinois. 7 FDA inspections on record, 1 Form 483, 1 warning letter, last inspected April 12, 2024. Publicly traded as NYSE: TAK.
Company Profile
This profile covers Takeda Pharmaceutical Company Limited based in Round Lake, Illinois, Japan.
FDA Inspection History
- FDA inspections
- 7
- OAI
- 0
- VAI
- 5
- NAI
- 2
- Form 483s
- 1
- Warning letters
- 1
First inspected September 14, 2010. Last inspected April 12, 2024.
Most cited issue areas
- Complete test data included in records1 inspection
- Control procedures to monitor and validate performance1 inspection
- Investigations of discrepancies, failures1 inspection
FDA inspections (7)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 12, 2024 | NAI | Human Drugs · Drug Quality Assurance | 1238763 |
| August 9, 2019 | VAI | Human Drugs · Drug Quality Assurance | 1100693 |
| August 29, 2017 | NAI | Human Drugs · Drug Quality Assurance | 1028828 |
| September 18, 2015 | VAI | Human Drugs · Drug Quality Assurance | 943082 |
| September 6, 2013 | VAI | Human Drugs · Drug Quality Assurance | 853928 |
| August 2, 2012 | VAI | Human Drugs · Drug Quality Assurance | 793427 |
| September 14, 2010 | VAI | Human Drugs · Drug Quality Assurance | 682755 |
FDA documents
Warning Letters (1)
People (6)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Takeda Pharmaceutical Company Limited
Stock ticker
TAK
Exchange
NYSE
Share price
$21.13
Market cap
$66.8B
Price as of
November 13, 2026
FEI Number
3002808311
Address
25212 W Il Route 120, Round Lake, Illinois 60073, Japan
Country
Japan
ID: 185c125c-128f-47be-ab1b-e1d5324bcc21